Springfield, NJ, United States of America

Iikka Larma

This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iikka Larma. Retrieved from https://idiyas.com/inventor/iikka-larma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Iikka Larma: Innovator in Controlled Release Pharmaceutical Compositions

Introduction

Iikka Larma is a notable inventor based in Springfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. His work focuses on improving the efficacy and safety of medications used in treating serious health conditions.

Latest Patents

Larma holds a patent for "Controlled release peroral compositions of levosimendan." This invention pertains to peroral pharmaceutical compositions that release levosimendan in a controlled manner, thereby reducing the occurrence of undesired effects. Levosimendan is particularly useful in the treatment of congestive heart failure, making this innovation crucial for patient care.

Career Highlights

Iikka Larma is associated with Orion Corporation, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Orion has allowed him to focus on advancing drug delivery systems that enhance therapeutic outcomes for patients.

Collaborations

Larma has collaborated with talented professionals such as Maarit Bäckman and Saila Antila. These partnerships have contributed to the successful development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Iikka Larma's contributions to controlled release pharmaceutical compositions exemplify the importance of innovation in healthcare. His work not only advances medical science but also improves the quality of life for patients suffering from congestive heart failure.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…